Agency of record.(Industry News)(marketing contracts of McIK
Healthcare and Alliant Pharmaceuticals Inc.)(Brief article)
McIK Healthcare, Boston, has been named the agency of record to
launch Alliant Pharmaceuticals, Inc.'s (Alpharetta, GA) Orapred ODT
(prednisolone sodium phosphate orally disintegrating tablets), . . .
Discontinued alliance.(Industry News)(Sanofi-Aventis KK and
Astellas Pharma, Inc.)(Brief article)
Sanofi-Aventis KK and Astellas Pharma, Inc., both headquartered in
Tokyo, Japan, will discontinue their marketing alliance for Ketek 300-mg
tablets (telithromycin). Sanofi-Aventis will solely . . .
Expanded access.(Industry News)(Merck and Company Inc)(Brief
article)
Merck & Co., Inc. (Whitehouse Station, NJ) will launch a
worldwide access program regarding MK-0518, currently in phase 3
development, for patients with human immunodeficiency virus
(HIV)/acquired . . .
Ten-year anniversary.(Industry News)(DoctorDirectory.com )(Brief
article)
DoctorDirectory.com will celebrate its 10-year anniversary. The
on-line service assists patients in finding doctors, provides physicians
with services for their profession, and offers brand . . .
Exclusive agreement.(Industry News)(e-Healthcare Solutions sings
advertising agreement with American College of Surgeons )(Brief
e-Healthcare Solutions (Ewing, NJ) has signed an exclusive
agreement with the American College of Surgeons (ACS), Chicago, making
the agency the sole provider of advertising for the . . .
Tax settlement.(Industry News)(Brief article)
GlaxoSmithKline (Research Triangle Park, NC) has agreed to issue
the Internal Revenue Service (IRS) $3.4 billion to settle claims that
the company underpaid U.S. taxes since 1989 by shifting . . .
Divide and conquer: novel patient-segmentation approach leads to
new opportunities: anonymized patient-level data can be used to
Patient segmentation puts a new twist on the age-old concept of
"divide and conquer." Instead of a strategy for maintaining
power over vast empires, it describes the way pharmaceutical . . .
Just the fax: the detail/marketing preferences of doctors
revealed.(Health Care Briefs)
How do physicians prefer to receive marketing communications? Is it
E-detailing or E-mail? According to the results of the Prescriber
Marketing Survey, conducted by PharmaKinnex, Inc., East . . .
Medicare part D: short-term gains, long-term potential.(Health
Care Briefs)
Verispan (Yardley, PA) measured Medicare part D's effect on
the top 10 retail pharmaceutical companies during the first seven months
of 2006. The agency revealed that five companies averaged nearly . . .
Leveraging a brand's medical moment of truth.(Guest
Viewpoint)
Committing extensive resources to detailing doctors and heavily
marketing to patients using traditional DTC venues are standard
techniques used by pharmaceutical companies to educate their . . .
New gabapentin generic.(FDA Focus)(Brief article)
Apotex Inc (Weston, Ontario, Canada), has introduced its oral
gabapentin generic. In prescription strengths of 600 mg and 800 mg,
gabapentin is approved for use as adjunctive therapy for patients . . .
Generic agent to join the cancer fight.(FDA
Focus)(epirubicin)(Brief article)
Epirubicin, an antibiotic antineoplastic injectable, has received
approval from the FDA. The generic medication, produced by Mayne Pharma
USA (Paramus, NJ), is a component of combination adjuvant . . .
Muscle relaxant approved.(FDA Focus)(baclofen tablets)(Brief
article)
The FDA announced final approval of Detroit-based Caraco
Pharmaceutical Laboratories' ANDA for baclofen tablets, 10 and 20
mg. The drug is a muscle relaxant and antispastic, and the . . .
Marketing exclusivity extended to January.(FDA Focus)(Brief
article)
Salix Pharmaceuticals, Ltd., Raleigh, North Carolina, announced
that the FDA granted Colazal (balsalazide) additional marketing
exclusivity until January 8, 2007. The drug is an antiinflammatory . . .
Generic antibiotic injection.(FDA Focus)(Brief article)
The FDA approved several abbreviated new drug applications (ANDAs)
for generic versions of intravenous ciprofloxacin, the prototype
fluoroquinolone drug, which is used to treat certain . . .
Emergency OTC contraceptive.(FDA Focus)(Brief article)
Barr Pharmaceuticals, Inc., Woodcliff Lake, New Jersey, received
FDA approval to sell Plan B (levonorgestrel) emergency contraceptive on
an OTC basis to those 18 years of age and older. Marketed by . . .
Influenza vaccines.(FDA Focus)(Brief article)
The FDA has approved this year's seasonal influenza vaccines.
The approved formulation for the U.S. vaccine is identical to that
recommended by the World Health Organization, and includes one . . .
Myoclonic seizure therapy.(FDA Focus)(Brief article)
The FDA granted an additional indication for Keppra
(levetiracetam), manufactured by UCB (Brussels, Belgium), as an
adjunctive therapy in the treatment of myoclonic seizures in adults . . .
Preventing invasive fungal infections.(FDA Focus)(Brief
article)
The FDA has approved Kenilworth, New Jersey-based Schering-Plough
Corporation's Noxafil (posaconazole) oral suspension, indicated to
prevent invasive Aspergillus and Candida infections in patients . . .
Synchronizing for success: integrated brand marketing can offer
an effective and synchronized brand message, but overcoming the
When watching rowing crews gliding down a river, it is clear that
the frontrunners in the competition are always the strongest, most
synchronized teams. Promotional competitions in the marketplace . . .
|
|